Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
28.32
-0.16 (-0.56%)
Sep 29, 2026, 12:07 PM EDT - Market open
Neurogene Employees
Neurogene had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year.
Employees
131
Change (1Y)
24
Growth (1Y)
22.43%
Revenue / Employee
n/a
Profits / Employee
-$848,168
Market Cap
566.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Jun 30, 2023 | 82 | - | - |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| Phathom Pharmaceuticals | 371 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| MapLight Therapeutics | 133 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Altimmune | 57 |
NGNE News
- 13 days ago - Neurogene Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 21 days ago - Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 24 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Neurogene price target lowered to $65 from $70 at H.C. Wainwright - TheFly
- 6 weeks ago - Neurogene price target raised to $81 from $69 at Guggenheim - TheFly
- 6 weeks ago - Neurogene price target lowered to $166 from $180 at Canaccord - TheFly
- 7 weeks ago - Neurogene Slides: Corporate presentation - Filings
- 7 weeks ago - Neurogene reports Q2 EPS ($1.53), consensus ($1.38) - TheFly